Prostate Cancer
Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer.
April 18, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer.
April 18, 2024
ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity.
April 18, 2024
Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in Canada.
April 17, 2024
Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review.
April 16, 2024
Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy.
April 16, 2024